Ignite Creation Date:
2025-12-24 @ 11:30 PM
Ignite Modification Date:
2025-12-25 @ 9:17 PM
Study NCT ID:
NCT04975256
Status:
TERMINATED
Last Update Posted:
2024-12-16
First Post:
2021-07-06
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Adagrasib in Combination With BI 1701963 in Patients With Cancer (KRYSTAL 14)
Sponsor:
Mirati Therapeutics Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-07-28
Start Date Type:
ACTUAL
Primary Completion Date:
2022-11-02
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-11-15
Completion Date Type:
ACTUAL
First Submit Date:
2021-07-06
First Submit QC Date:
None
Study First Post Date:
2021-07-23
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-12-12
Last Update Post Date:
2024-12-16
Last Update Post Date Type:
ACTUAL